5-Fluorouracil-associated bradycardia: case report

Basit Öğe Kaydı
dc.contributor.authorKaplan, Muhammet Ali
dc.contributor.authorCil, Timucin
dc.contributor.authorIsikdogan, Abdurrahman
dc.date.accessioned2024-04-24T17:33:09Z
dc.date.available2024-04-24T17:33:09Z
dc.date.issued2010
dc.departmentDicle Üniversitesien_US
dc.description.abstract5-Fluorouracil (5-FU) is a synthetic, fluorinated pyrimidine antagonist, which is a cytostatic agent. Cardiotoxicity is a rare but important side effect of 5-FU. The cardiotoxicity incidence of 5-FU is increasing in conjunction with its frequent use in chemotherapy protocols. Ischemic symptoms and signs related to 5-FU are observed during the late phase of the drug administration. Monitoring should be done in all patients having coronary artery disease. There are many treatment options and prophylactic modalities for 5-FU cardiotoxicity. Herein, we present the rare case of a patient with cardiotoxicity during short 5-FU infusion.en_US
dc.identifier.endpage118en_US
dc.identifier.issn1300-7467
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-78650538296
dc.identifier.scopusqualityQ4
dc.identifier.startpage115en_US
dc.identifier.urihttps://hdl.handle.net/11468/20484
dc.identifier.volume25en_US
dc.identifier.wosWOS:000439264400005
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.publisherKare Publen_US
dc.relation.ispartofTurk Onkoloji Dergisi-Turkish Journal of Oncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBradycardiaen_US
dc.subjectChemotherapyen_US
dc.subject5-Fluorouracilen_US
dc.title5-Fluorouracil-associated bradycardia: case reporten_US
dc.title5-Fluorouracil-associated bradycardia: case report
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu